Even though most people in the U.S. have been eligible for COVID-19 vaccines and boosters for quite some time, children under 5 still don’t have vaccine options. Now, lawmakers are asking the FDA to lay out its plans in this age group—and address a perceived delay for Moderna’s product.
Yesterday, Congress’s Select Subcommittee on the Coronavirus Crisis sent a letter to FDA Commissioner Robert Califf, M.D., requesting a briefing on the status of COVID-19 vaccines for the under 5 age group.
